Work

Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority

Year: 2025

Type: article

Source: Journal of the European Academy of Dermatology and Venereology

DOI: 10.1111/jdv.20691

Authors: David Saceda‐Corralo, Sergio Vañó‐Galván

Institutions: Universidad de Alcalá, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal

Language: English

Topic: Hair Growth and Disorders

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Pfizer

OpenAlex ID: W4410746279

FWCI: 1.848

Cites: 4

Cited by: 2

Related to: 10